Participated · Equity · Mar 2026

Photo electron Soul was founded in 2015 as a Nagoya University spinout and is headquartered in Nagoya, Aichi. The company commercializes a semiconductor photocathode electron-beam generation technology developed over more than 30 years at Nagoya University and positions itself as the only supplier of industrial semiconductor photocathode electron-beam generation systems. Its strategy focuses on transitioning to volume production and establishing maintenance and support capabilities while expanding into inspection, metrology, and advanced patterning applications. Photo electron Soul is pursuing strategic partnerships and capital ties—most notably with 芝浦メカトロニクス—to scale manufacturing and access semiconductor clusters in Kumamoto and Taiwan. The company reports cumulative funding of about ¥4.0 billion and is using recent proceeds to accelerate product development, production scale-up, and global customer expansion.

Participated · Series A · Jan 2026

Linker Vision develops an AI software platform that combines Physical AI and Reasoning AI technologies to enable large-scale deployment of smart-city and smart-space solutions. Its platform supports use cases across industrial automation, enterprise analytics, telecom AI, humanoid robotics, and autonomous services. By providing end-to-end tools for building, deploying, and managing AI models, the company targets governments, enterprises, and service operators that require scalable, real-time intelligence. With fresh capital, Linker Vision plans to broaden its geographic presence across the United States, Latin America, Asia, the Middle East, and Europe. The company will also accelerate product development, deepen platform integration, and recruit top global talent to maintain technological leadership. Although no revenue or user metrics were disclosed, the Series A round underscores investor confidence in the firm’s vision to drive the next wave of AI innovation.

Participated · Series A · Apr 2024

Rivos develops RISC-V-based server chipsets with a data-parallel accelerator designed to speed AI and big-data analytics. Its prototype chip was made using TSMC’s 3nm process and the company is also building self-contained Open Compute Project–style data center hardware plus a firmware-to-app software stack. Rivos targets customers building generative AI and other data-driven solutions and plans to monetize via hardware sales and complementary software to large data center operators. The company is pre-revenue, has roughly 375 employees, and CEO Puneet Kumar said it holds hundreds of millions of dollars in the bank. Rivos was founded in 2021 and previously faced litigation with Apple that settled in February, a legal shadow that had complicated hiring and fundraising. The company does not expect mass production of its chip until sometime next year and emphasizes a “recompile-not-redesign” approach to ease customer adoption.

Participated · Series B · Aug 2020

iKala provides AI-driven cloud services and marketing-technology solutions, with a flagship product KOL Radar, an AI influencer platform covering over three million global influencers. The company serves more than 1,000 enterprises, including Fortune 500 firms, across Asian markets such as Japan, Hong Kong, Singapore, Malaysia, Thailand, and Vietnam. iKala focuses on AI research and development, cloud deployment, and AI-driven marketing solutions to help businesses improve customer acquisition and marketing efficiency. The company plans to use its latest funding to boost AI R&D and expand its presence in Japan and Southeast Asia. Its stated mission is to empower businesses with AI-driven tools to enhance marketing efficiency. Founders named in the reporting are Shijia Cheng, Ju-Chia Hsu, and Keynes Cheng. iKala is an AI-based customer acquisition and engagement platform that provides tools for e-commerce companies. Its products include KOL Radar for influencer marketing and Shoplus, a social commerce service focused on Southeast Asian markets. The company raised a $17 million Series B, bringing total capital raised to $30.3 million. The funding will be used to launch in Indonesia and Malaysia and to expand in existing markets including Singapore, Thailand, Hong Kong, the Philippines, Vietnam and Japan. The round was led by Wistron Digital Technology Holding Company, which will serve as a strategic investor and marks Wistron's entry into Southeast Asia, with returning investors Hotung Investment Holdings Limited and Pacific Venture Partners participating. iKala is based in Taiwan and aims to help position Taiwanese startups and talent in AI across the region. iKala is a Taiwan-based, AI-driven marketing technology startup. The company develops marketing-technology products powered by artificial intelligence. According to the article, iKala has secured $10 million in a Series A+ financing. The funding announcement was reported in an Asia digest alongside separate coverage that GaiaWorks closed a Series C. The article does not disclose participating investors, valuation, founding year, or operating metrics. No future plans or use of proceeds were described in the report.

Participated · Equity · Jan 2019

EarlySense, led by CEO Avner Halperin, develops contact-free continuous monitoring solutions used worldwide across the care continuum. Its FDA-cleared and CE-approved systems are deployed in hospitals, post-acute facilities and homes to assist clinicians in early detection of patient deterioration. The technology leverages artificial intelligence and big data analytics to deliver actionable health insights. EarlySense says its solutions have been proven to help prevent adverse events including code blue events, preventable ICU transfers, patient falls, pressure ulcers and hospital readmissions. The company is headquartered in Ramat Gan, Israel and Woburn, Massachusetts, and recently completed a $39M financing round. EarlySense provides an FDA-cleared and CE-approved contact-free continuous monitoring system that tracks patient heart rate, respiratory rate and movement via a sensor placed under the mattress. Continuous data is displayed on bedside monitors, nurse monitoring stations and delivered to clinicians’ smart devices. The company’s technology leverages Big Data and advanced algorithms to generate accurate health information for early detection of adverse events and improved patient outcomes. Its sensor technology also powers consumer products including Samsung’s SleepSense, iFit’s Sleep Sensor and Beurer’s SE 80 Sleep Expert. The company intends to use the new funding to continue to grow and to launch consumer digital health offerings based on its proven technology. EarlySense was founded in 2004 and is led by CEO Avner Halperin, with operations in Waltham, MA and Ramat Gan, Israel. EarlySense has developed a platform based on algorithms, analytics and smart Health/IT capabilities for contact-free, continuous monitoring of heart and respiratory rate, as well as movement and sleep. The system is installed in hospitals, rehabilitation centers and homes across the USA, Europe, Asia and Australia. EarlySense also offers OEM solutions for companies looking to add contact-free and continuous sensing capabilities to their products. The company is led by CEO Avner Halperin and has US headquarters in Waltham, MA while being based in Ramat Gan, Israel. EarlySense completed a $20M financing and intends to use the funds to continue to expand operations. EarlySense is described as the market leader in proactive patient care solutions, with a flagship contact‑free system that monitors and documents patients' vital signs and movement via a sensor placed beneath a mattress. The system requires no leads or cuffs, allowing patients freedom of movement, and is designed primarily for non‑ICU 'lower risk' patients on medical‑surgical floors. EarlySense's technology is installed in hospitals and rehabilitation centers across the U.S. and Europe and is commercially available in Canada. The company plans to use new financing to accelerate sales, further develop its contact‑free monitoring solutions, expand clinical research, and support global commercialization efforts. EarlySense is headquartered in Waltham, MA. EarlySense commercializes an automatic, continuous, contact-free patient monitoring system that documents vital signs and movement without leads or cuffs. The system is installed in hospitals and rehabilitation centers in the USA and Europe and is commercially available in Canada. Management and new board member Peter Soderberg see opportunities for rapid market growth initially in hospital and long‑term care markets and subsequently in the home market. The company recently received new innovative technology status from Novation and published clinical results from a Dignity Health study with Harvard‑affiliated support showing improved clinical outcomes. EarlySense is headquartered in Waltham, MA and lists investors including JK&B, Pitango Venture Capital, Etgar Challenge Fund, ProSeed VC Fund (TASE: PRSD), Docor International Management, Noaber, and Bridge Investment Fund. The press release does not disclose operating metrics such as revenue or user counts.